Warp Sciences

US chemistry contract research organization that combines medicinal chemists, AI and lab robotics to make research compounds for biotech and pharma drug discovery teams.

Warp Sciences has raised $215M across 1 disclosed round since Oct 22, 2026; the latest round, Series A, was announced on Oct 22, 2026. Data as of Oct 23, 2026.

Headquartered in United States.